272 related articles for article (PubMed ID: 22692074)
1. Targeted lipid based drug conjugates: a novel strategy for drug delivery.
Vadlapudi AD; Vadlapatla RK; Kwatra D; Earla R; Samanta SK; Pal D; Mitra AK
Int J Pharm; 2012 Sep; 434(1-2):315-24. PubMed ID: 22692074
[TBL] [Abstract][Full Text] [Related]
2. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.
Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK
Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675
[TBL] [Abstract][Full Text] [Related]
3. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
Vadlapudi AD; Cholkar K; Vadlapatla RK; Mitra AK
J Ocul Pharmacol Ther; 2014 Feb; 30(1):49-58. PubMed ID: 24192229
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.
Luo S; Kansara VS; Zhu X; Mandava NK; Pal D; Mitra AK
Mol Pharm; 2006; 3(3):329-39. PubMed ID: 16749865
[TBL] [Abstract][Full Text] [Related]
5. Functional and molecular aspects of biotin uptake via SMVT in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells.
Vadlapudi AD; Vadlapatla RK; Pal D; Mitra AK
AAPS J; 2012 Dec; 14(4):832-42. PubMed ID: 22927035
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
7. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
8. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
12. Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.
Gokulgandhi MR; Barot M; Bagui M; Pal D; Mitra AK
J Pharm Sci; 2012 Sep; 101(9):3249-63. PubMed ID: 22499243
[TBL] [Abstract][Full Text] [Related]
13. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
14. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
15. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line.
Tak RV; Pal D; Gao H; Dey S; Mitra AK
J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709
[TBL] [Abstract][Full Text] [Related]
16. Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide.
Ramanathan S; Pooyan S; Stein S; Prasad PD; Wang J; Leibowitz MJ; Ganapathy V; Sinko PJ
Pharm Res; 2001 Jul; 18(7):950-6. PubMed ID: 11496954
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
18. Increased acyclovir oral bioavailability via a bile acid conjugate.
Tolle-Sander S; Lentz KA; Maeda DY; Coop A; Polli JE
Mol Pharm; 2004 Jan; 1(1):40-8. PubMed ID: 15832499
[TBL] [Abstract][Full Text] [Related]
19. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
Luo S; Wang Z; Patel M; Khurana V; Zhu X; Pal D; Mitra AK
Int J Pharm; 2011 Jul; 414(1-2):77-85. PubMed ID: 21571053
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
Talluri RS; Samanta SK; Gaudana R; Mitra AK
Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
